Here are four observations:
1. The notice of allowance is for the company’s application for its “Devices and Methods for the Regeneration of Bony Defects.”
2. This is the second allowance for a collagen/bioactive glass device in the last 90 days.
3. NovaBone Products recently received patent issuance for the first allowance establishing intellectual property for Novabone.
4. The privately held company is a focuses on developing NovaBone, a bioactive synthetic bone graft.
More articles on devices:
39 spine, orthopedic devices receive FDA 510(k) clearance in August
5 new device launches & releases — September 28, 2015
Stryker Navigation’s SpineMask tracker cuts down incisions during spine surgery: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
